China Traditional Chinese Medicine Co. Limited provided earnings guidance for the year ended December 31, 2015. For the period, the company expects to record an increase of not less than 50% in consolidated net profit attributable to the shareholders for the year ended 31 December 2015 as compared with that of approximately RMB 413.1 million for the year ended 31 December 2014.

The improvement in the results of the Group for the year ended 31 December 2015 as compared with that for 2014 was mainly attributable to the completion of the acquisition of and the consolidation of the financial results of Jiangyin Tianjiang Pharmaceutical Co. Ltd. and its subsidiaries since October 2015; and the gain from the disposal of equity interest in a subsidiary.